Clinical Trial Update: A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating pemetrexed with either carboplatin or cisplatin plus radiation therapy followed by pemetrexed in patients with inoperable non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Carboplatin (Paraplatin) (carboplatin)
• Cisplatin (Platinol) (cisplatin)
• Pemetrexed (Alimta) (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-Small-Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-11-27